Hospital leaders looking to improve care delivery while lowering costs should focus their operations management efforts on the emergency department (ED) and should consider embracing the door-to-doc model (D2D) to match patient demand to services, beds and providers, according to a recent column published in Hospitals & Health Networks Daily.
For every 1% of patients who leave before a care provider sees them, EDs with volumes of 50,000 patients lose revenue worth approximately $500,000, according to the article.
The D2D model acknowledges that patient demand and variability are predictable. The model, therefore, bases staffing of more ED workers during the busy hours and fewer staff members during the slow times of the day.
Read more at: http://tinyurl.com/83uldnm
Source: FierceHealthcare
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More